The Corporate Governance Report presents the structure, rules and processes that form the basis of Lonza’s corporate governance. The Report follows the structure of the SIX Swiss Exchange’s Directive on Information relating to Corporate Governance. The principles and rules of Lonza’s corporate governance are laid down in the Lonza Articles of Association and in the Regulations Governing Internal Organization and Board Committees, including their Charters. In the implementation of its corporate governance, Lonza follows the Swiss Code of Best Practice for Corporate Governance issued by the Swiss Business Federation economiesuisse.
Rodolfo J. Savitzky was Chief Financial Officer until November 2021
Claude Dartiguelongue was President, Capsules & Health Ingredients until July 2022
Jean-Christophe Hyvert was President, Cell & Gene until November 2022
Nationality: Swiss
Year of birth: 1952
Chairman of the Board of Directors of Lonza Group Ltd (since 2018), Independent member of the Board of Directors of Lonza Group Ltd (since April 2017).
Albert M. Baehny holds a degree in biology from the University of Fribourg (CH).
Nationality: Swiss
Year of birth: 1959
Vice-Chairman (since April 2020) and Lead Independent Director (since November 2019) of the Board of Directors of Lonza Group Ltd (since April 2020); Independent member of the Board of Directors of Lonza Group Ltd (since April 2016).
Christoph Mäder holds a Master’s degree in law from the University of Basel (CH) and is admitted to the Swiss Bar.
Nationality: German
Year of birth: 1965
Independent member of the Board of Directors of Lonza Group Ltd (since May 2022).
Marion Helmes has extensive financial expertise as well as global operational experience from a career that includes Chief Financial Officer positions at Celesio, Q-Cells and with ThyssenKrupp’s Elevator and Stainless divisions. She currently holds Board Memberships with ProSiebenSat.1 Media, Siemens Healthineers AG and Heineken N.V.
Marion has a degree in Business Administration from Freie Universität Berlin and a PhD from the University of St. Gallen.
Nationality: German-Brazilian
Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).
Angelica Kohlmann holds a MD and doctorate in medicine from Hamburg University (DE).
Nationality: Swiss, German
Year of birth: 1961
Independent member of the Board of Directors of Lonza Group Ltd (since May 2022).
Roger Nitsch serves as CEO and President of Neurimmune, which he founded in 2006 with two business partners. A neuroscientist with a background in medicine, Roger is recognized as an opinion leader in neurodegenerative diseases with over 30 years of experience in Alzheimer’s disease research. A Potamkin Prize winner and Member of the German Academy of Sciences, Roger served as a founding director of the Institute for Regenerative Medicine (IREM), University of Zurich.
He holds an MD degree from the University of Heidelberg and earned his post-doctoral qualification at the Massachusetts Institute of Technology and Harvard Medical School.
Nationality: British
Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since April 2014).
Barbara Richmond holds a first-class degree in management science from the University of Manchester Institute of Science and Technology in England. Barbara Richmond has substantial knowledge as a financial expert, demonstrated by her roles as Chief Financial Officer for various companies. She is a Fellow of the Institute of Chartered Accountants in England and Wales.
Nationality: German
Year of birth: 1958
Independent member of the Board of Directors of Lonza Group Ltd (since April 2014). Jürgen Steinemann holds a degree in Economics and Business Management from the European Business School in Wiesbaden (DE), London (UK) and Paris (FR).
Nationality: Belgian
Year of birth: 1972
Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).
Olivier Verscheure holds a PhD in computer science from the Swiss Federal Institute of Technology, Lausanne (CH) (EPFL, July 1999).
Nationality: Swiss
Year of birth: 1950
Independent member of the Board of Directors of Lonza Group Ltd (April 2013 until May 2022).
Werner Bauer holds a diploma and PhD in chemical engineering from the University of Erlangen-Nürnberg (DE). He has received several scientific honors, among others the BioAlps Award 2011 and Honorary Senator from the Technical University of Munich (DE).
Nationality: Austrian
Year of birth: 1968
Independent member of the Board of Directors of Lonza Group Ltd (April 2020 until May 2022).
Non-Executive Director and Corporate Finance Adviser, who brings more than 25 years of experience in the fields of manufacturing, biotech, pharmaceuticals and banking. Ms Deuring currently serves on the board of several companies including Axpo, Bilfinger and Elementis. Her Board memberships span the energy, plant engineering, chemical and biopharmaceutical sectors. She received her Master of Science in Chemistry from Université Louis Pasteur, Strasbourg in 1994. In 1996 she received her Master in Business Administration from INSEAD, Fontainebleau (FR).
Nationality: Swiss
Year of birth: 1969
Chief Executive Officer (CEO) and Member of the Executive Committee (since November 2020).
Pierre-Alain Ruffieux holds a doctorate in Biotechnology and a master’s degree in Chemical Engineering and Biotechnology from the Swiss Federal Institute of Technology (EPFL), Lausanne (CH).
Nationality: Swiss / German / French
Year of birth: 1972
Chief Financial Officer (CFO) and Member of the Executive Committee (since December 2021).
Philippe Deecke holds a Master’s Degree in Industrial Management and Manufacturing from ETH Zurich (CH) and an MBA from Cornell University Johnson School (US).
Nationality: British, Swiss
Year of birth: 1972
Chief Human Resources Officer (CHRO) and Member of the Executive Committee (since April 2020).
Caroline Barth holds a degree in European Business Studies from the University of Sunderland (UK) and an MBA from The Open University (BE).
Nationality: Spanish
Year of birth: 1969
Head, Group Operations and Member of the Executive Committee (since August 2022).
Maria Soler Nunez holds a PhD in Pharmacy in the area of Genetics, Molecular Biology from the Universidad Complutense de Madrid (ES).
Nationality: German
Year of birth: 1975
President, Capsules & Health Ingredients Division and Member of the Executive Committee (since July 2022).
Christian Seufert holds a master’s degree in Business Administration and Economics from the University of Hohenheim (DE).
Nationality: British
Year of birth: 1965
President, Small Molecules Division (since January 2021) and Member of the Executive Committee (since April 2021).
Gordon Bates holds a master’s degree in Engineering Business Management from the University of Warwick (UK).
Nationality: Swiss
Year of birth: 1972
President, Biologics Division (since January 2021) and Member of the Executive Committee (since April 2021).
Jean-Christophe Hyvert holds a master’s degree in Physics from INSA, Rennes (FR) and an MBA from the Northwestern University (USA).
Nationality: German, Italian, US
Year of birth: 1969
President, Cell & Gene Division and Member of the Executive Committee (since November 2022).
Daniel Palmacci holds a Master’s Degree in Chemistry and Process Engineering with High Honors from the Technical University Berlin (DE).
Nationality: Swiss
Year of birth: 1966
Head, Group Operations and Member of the Executive Committee (March 2019 until August 2022).
Stefan Stoffel holds a Bachelor’s degree in engineering from Lucerne University of Applied Sciences and Arts (CH).
Nationality: French
Year of birth: 1959
President, Capsules & Health Ingredients Division (since January 2020) and Member of the Executive Committee (since April 2021).
Claude Dartiguelongue holds a master’s degree in Medical Management from the École Superieure de Commerce de Paris, ESCP (FR), as well as in Biotechnology from the University of Grenoble (FR).
Information tracked until the end of the term of employment with Lonza
